Alerts will be sent to your verified email
Verify Email
BLISSGVS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Bliss GVS Pharma Limited is a global leader in Suppositories and Pessaries, offering high-quality pharmaceutical formulations at affordable prices. With a strong presence in over sixty countries, the company is rapidly growing through advancements in R&D, manufacturing, and marketing.
Bliss GVS Pharma major competitors are Novartis, Beta Drugs, Panacea Biotec, Syncom Formulations, Jagsonpal Pharma, Indoco Remedies, Venus Remedies.
Market Cap of Bliss GVS Pharma is ₹1,808 Crs.
While the median market cap of its peers are ₹1,648 Crs.
Bliss GVS Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | Mar Jun | Mar Jun Sep Dec | Dec | |||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
